On September 20, 2021, Swedish Medical Technologies Product (MTP) Council announced ongoing horizon scanning for medical technology products used in asthma and chronic obstructive pulmonary disease (COPD) within the Orderly introduction framework.
This framework aimed to manage the national introduction of novel technologies is permanent from the beginning of 2020. This is a staged process, including horizon scanning, selection of the method for evaluation, the decision on national collaboration, health economic evaluation, and recommendations by MTP Council to regions about the introduction of the method and criteria for use.
As a horizon scanning stage, the Dental and Pharmaceutical Benefits Agency (TLV) is conducting a thematic survey for technologies in obstructive pulmonary diseases. Products of interest should support the patient's self-monitoring and can be integrated with a treatment plan.
The full details in Swedish can be found here.
This news is just one of about 300 market access news collected by our team in the subscription services "HTA Alerts" and "Reimbursement Alerts" every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). First EU issues of both newsletters are available for download free-of-charge.
Not ready for a subscription service? Subscribe to our free-of-charge newsletter delivered every second week to get updates about key reimbursement developments in Europe (10-12 news every two weeks).